scholarly article | Q13442814 |
P356 | DOI | 10.1586/17476348.2.5.663 |
P8608 | Fatcat ID | release_k4ixymsemvhkrj5fb5htoxrf2a |
P698 | PubMed publication ID | 20477301 |
P50 | author | Shabir A. Madhi | Q56065756 |
Keith P. Klugman | Q79427702 | ||
P2093 | author name string | Barry Schoub | |
P2860 | cites work | Influenza pandemics of the 20th century | Q22305643 |
Etiology and treatment of community-acquired pneumonia in ambulatory children | Q28137848 | ||
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia | Q28262914 | ||
Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor | Q28289854 | ||
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis | Q28297061 | ||
Transmissibility of 1918 pandemic influenza | Q28298620 | ||
Pandemic influenza preparedness in Africa is a profound challenge for an already distressed region: analysis of national preparedness plans. | Q30229005 | ||
Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness | Q30230662 | ||
A role for Streptococcus pneumoniae in virus-associated pneumonia | Q45615871 | ||
The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children | Q46973033 | ||
Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia | Q47745871 | ||
Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation | Q47839068 | ||
Impact of pneumococcal conjugate vaccine and the severity of winter influenza-like illnesses on invasive pneumococcal infections in children and adults | Q47861214 | ||
A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology | Q47875651 | ||
The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. | Q50656110 | ||
Mortality from pneumonia in children in the United States, 1939 through 1996. | Q30326792 | ||
Planning for the next pandemic of influenza. | Q30327977 | ||
Oseltamivir in the management of influenza. | Q30351736 | ||
Insights into the interaction between influenza virus and pneumococcus | Q30355570 | ||
Cases and deaths during influenza pandemics in the United States. | Q30356240 | ||
Scientific lessons from the first influenza pandemic of the 20th century. | Q30357693 | ||
Avian influenza: a review. | Q30359165 | ||
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia | Q30365855 | ||
Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. | Q30367425 | ||
Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. | Q30368450 | ||
Occurrence of invasive pneumococcal disease and number of excess cases due to influenza | Q33237086 | ||
Otitis media: the chinchilla model | Q33637886 | ||
A newly discovered human pneumovirus isolated from young children with respiratory tract disease | Q33845279 | ||
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group | Q33896897 | ||
Etiology and treatment of pneumonia | Q33900046 | ||
Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection | Q35220396 | ||
Respiratory viruses predisposing to bacterial infections: role of neuraminidase | Q35632383 | ||
Retrospective review of serious bacterial infections in infants who are 0 to 36 months of age and have influenza A infection | Q36059201 | ||
Childhood pneumonia mortality--a permanent global emergency | Q36894009 | ||
Newly discovered respiratory viruses: significance and implications | Q36906083 | ||
The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza | Q37275782 | ||
Influenza virus neuraminidase contributes to secondary bacterial pneumonia | Q37275790 | ||
Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans | Q37334291 | ||
Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children | Q37867448 | ||
Etiology of childhood pneumonia: serologic results of a prospective, population-based study | Q37879574 | ||
Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza | Q40537661 | ||
Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae | Q40660949 | ||
Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand | Q43176420 | ||
The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. | Q43176718 | ||
Incidence and characteristics of viral community-acquired pneumonia in adults. | Q43708189 | ||
Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses | Q43737309 | ||
Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection | Q43812278 | ||
Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium | Q43919578 | ||
Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor | Q44074391 | ||
Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia | Q44319772 | ||
Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection | Q45190347 | ||
Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine | Q45411475 | ||
Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season | Q45415593 | ||
Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice | Q45605059 | ||
P433 | issue | 5 | |
P921 | main subject | Streptococcus pneumoniae | Q221179 |
P304 | page(s) | 663-672 | |
P577 | publication date | 2008-10-01 | |
P1433 | published in | Expert Review of Respiratory Medicine | Q15754583 |
P1476 | title | Interaction between influenza virus and Streptococcus pneumoniae in severe pneumonia | |
P478 | volume | 2 |